Drug combo curbs viral load in difficult-to-treat hepatitis C cases

08/27/2013 | DoctorsLounge.com · MedPage Today (free registration)

Sofosbuvir plus ribavirin showed efficacy in reducing viral load in patients infected with hepatitis C who are considered unlikely to respond to treatment, according to a study published in the Journal of the American Medical Association. No deaths were recorded, and no patients stopped treatment due to adverse events.

View Full Article in:

DoctorsLounge.com · MedPage Today (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC